Carstens, Luisa
Popp, Margot
Keicher, Christian
Hertrampf, Rita
Weigner, David
Meiering, Marvin S. http://orcid.org/0000-0002-9747-5015
Luippold, Gerd
Süssmuth, Sigurd D.
Beckmann, Christian F.
Wunder, Andreas
Grimm, Simone
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 3 May 2023
Accepted: 6 November 2023
First Online: 27 November 2023
Declarations
:
: The study was approved by the local Ethical Review Boards (Landesamt für Gesundheit und Soziales, Geschäftsstelle der Ethik-Kommission des Landes Berlin, Berlin, Germany; reference number: 22/029 – IV E 11) and the Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany. Written, informed consent to participate is obtained from all participants.
: N/a.
: MP, GL, and AW are employees of Boehringer Ingelheim Pharma GmbH & Co. KG. SDS is full-time employee of Boehringer Ingelheim International GmbH and a member of the Faculty of Medicine of Ulm University without conflicts of interest. LC, CK, RH, DW, MSM, and SG declare no competing interests. CFB is the founder and shareholder of SBGneuro Ltd.